KPV 10mg

KPV 10 mg is a high-purity lyophilized peptide research compound supplied exclusively for scientific investigation and controlled laboratory experimentation. For research use only — not for human or veterinary use.  

Product Overview

KPV is a synthetic tripeptide research compound developed for advanced laboratory investigations involving peptide signalling, cellular communication and molecular regulatory pathways. KPV consists of the short amino acid sequence lysine-proline-valine. Its compact and precisely defined molecular structure has attracted scientific interest within peptide research, where investigators continue to explore short-chain peptide interactions and biochemical signalling mechanisms under carefully controlled laboratory conditions. This preparation contains 10 mg of lyophilized KPV supplied in a sealed research vial. Independent analytical testing confirmed an assay content of 10.24 mg for this production batch. Chromatographic analysis confirmed greater than 99.8 percent purity, while identity was independently evaluated through FTIR spectrum analysis, retention time confirmation and molecular ion mass identification. Microbiological testing reported 0 CFU/g for both total aerobic microbial count and total yeast and mold count, while bacterial endotoxin analysis returned a result of 0.101 EU/mg. Comprehensive elemental impurity screening additionally reported arsenic, cadmium, mercury, lead, nickel, vanadium and cobalt below 0.001 ppm. With its highly defined molecular identity, strong analytical purity and comprehensive third-party verification, KPV provides researchers with a well-characterised peptide material suitable for advanced peptide investigations and controlled in vitro laboratory studies.  

Peptide Overview

KPV is a synthetic tripeptide research compound commonly utilised in laboratory investigations involving peptide chemistry, molecular interactions and intracellular communication. The peptide consists of three amino acids — lysine, proline and valine — creating a compact molecular structure that can be characterised using modern chromatographic and mass spectrometric analytical techniques. Researchers employ KPV in controlled experimental models designed to investigate peptide-mediated signalling pathways, molecular interactions and complex biochemical regulatory systems. Its defined molecular structure and reproducible analytical characteristics have established KPV as a recognised compound within modern short-chain peptide research. Today, KPV continues to appear throughout experimental research involving peptide chemistry, molecular biology, cellular signalling and biochemical regulatory mechanisms.  

Historical Background and Scientific Context

Short-chain peptides have become increasingly important research materials within modern peptide chemistry because their compact molecular structures allow investigators to examine specific peptide interactions under highly controlled experimental conditions. Advances in peptide synthesis and analytical chemistry have significantly improved the ability to manufacture and independently characterise small peptide compounds such as KPV. Modern analytical technologies including ultra-high-performance liquid chromatography, FTIR identification and mass spectrometry allow researchers to evaluate peptide identity, assay content, purity and manufacturing consistency. These techniques can be complemented by bacterial endotoxin testing, microbiological analysis and elemental impurity screening to provide comprehensive batch-specific analytical documentation. Today, KPV remains part of the expanding field of investigational peptides utilised exclusively for scientific research and controlled in vitro experimentation.  

Mechanistic Focus in Research

Within controlled laboratory environments, KPV is commonly investigated in relation to short-chain peptide signalling, molecular interactions and cellular communication systems. Research investigations frequently explore:

• Short-chain peptide biology
• Peptide-mediated signalling pathways
• Intracellular molecular communication
• Cellular regulatory mechanisms
• Biochemical pathway analysis
• Molecular peptide interactions
• Comparative peptide investigations
• Controlled in vitro peptide studies

These experimental models allow researchers to investigate peptide-related molecular mechanisms while maintaining carefully controlled laboratory conditions.  

Analytical Verification (COA)

Each batch of KPV supplied by Grail Formula undergoes comprehensive independent third-party laboratory verification to confirm peptide identity, assay content, purity and microbiological quality. Analytical testing for this batch was performed by Liquilabs s.r.o. Czechia using chromatographic, spectrometric and microbiological analytical techniques. Batch: GF-KPV10-B243

• Assay Content: 10.24 mg
• Purity: greater than 99.8 %
• Identification by FTIR Spectrum: 996
• Identification by Retention Time: 0.987
• Molecular Ion Mass Identification: 342 Da
• Bacterial Endotoxins: 0.101 EU/mg
• Total Aerobic Microbial Count: 0 CFU/g
• Total Yeast and Mold Count: 0 CFU/g

Independent peptide screening measured an assay content of 10.24 mg with a reported analytical uncertainty of ±0.05 mg. Purity analysis confirmed greater than 99.8 percent purity for the tested KPV research material. Identity was evaluated through FTIR spectrum analysis with a reported result of 996 and retention time analysis with a result of 0.987. Mass spectrometry identified a molecular ion mass of 342 Da with a reported analytical uncertainty of ±1 Da, providing an additional independent identity parameter for the tested material. Bacterial endotoxin testing returned a result of 0.101 EU/mg, remaining within the laboratory’s stated acceptable range of 0–0.5 EU/mg. Microbiological testing reported 0 CFU/g for total aerobic microbial count and 0 CFU/g for total yeast and mold count. Independent elemental impurity analysis reported arsenic, cadmium, mercury, lead, nickel, vanadium and cobalt below 0.001 ppm. These analytical procedures provide independent confirmation of peptide identity, purity, traceability and important batch-specific laboratory quality parameters.  

Research Applications

Within controlled laboratory environments, KPV may be utilised in experimental models designed to investigate peptide biology, molecular signalling and biochemical regulatory mechanisms. Examples of research applications include:

• Short-chain peptide investigations
• Peptide signalling research
• Intracellular signalling investigations
• Molecular pathway analysis
• Biochemical regulation studies
• Comparative peptide investigations
• Molecular interaction research
• Controlled in vitro peptide studies

These applications are intended exclusively for scientific and laboratory investigation.  

Grail Formula Quality

Every Grail Formula research compound is supported by comprehensive independent analytical verification and transparent batch-specific laboratory documentation. Each production batch undergoes extensive testing to verify:

• Peptide identity confirmation
• Assay content verification
• Purity assessment
• Molecular ion mass verification
• Retention time confirmation
• FTIR spectrum identification
• Endotoxin analysis
• Microbial contamination screening
• Elemental impurity screening
• Complete batch traceability

Independent laboratory testing helps provide researchers with reliable, reproducible and transparently documented research material suitable for advanced scientific investigation.  

When You Choose Grail Formula

When selecting Grail Formula, researchers receive independently verified research compounds supported by complete Certificates of Analysis and transparent batch-specific laboratory documentation. Our analytical verification programme includes assay determination, purity confirmation, FTIR spectrum identification, retention time verification, molecular ion mass identification, endotoxin screening, microbiological analysis and comprehensive elemental impurity testing. Every production batch is accompanied by a downloadable Certificate of Analysis issued by Liquilabs s.r.o. Czechia, providing complete traceability and independent analytical verification of the tested research compound.  

Research Use Limitation

• Used solely for laboratory and in vitro research
• Not approved for human consumption
• Not approved for veterinary use
• Not intended for diagnostic purposes
• Not intended for therapeutic applications
• Not permitted for clinical administration
• For research use only

• Independently analysed by Liquilabs s.r.o. Czechia
• Greater than 99.8 % purity confirmed by COA
• Assay content verified at 8.74 mg
• Endotoxin level at 0.020 EU/mg
• No detectable heavy metals or microbial contamination
• High-purity peptide for controlled laboratory research
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.